Form 8-K CATALYST PHARMACEUTICALS For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Catalyst Pharmaceutical Partners (CPRX) PT Raised to $11 at SunTrust
August 8, 2019 1:03 PM EDTSunTrust analyst Edward Nash raised the price target on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) to $11.00 (from $9.00) while maintaining a Buy rating.
weakness a buying opportunity ahead of MuSK-MG topline in 1st-half of 2020... More
